Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Kumar S, Jacobus SJ, Cohen AD. et al.
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) for initial therapy of newly diagnosed multiple myeloma (NDMM): results of ENDURANCE (E1A11) phase III trial.

J Clin Oncol 2020;
38 (18) 3

Bibliographische Angaben herunterladen

Aufrufen in: